Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 163

1.

Dual method use among long-acting reversible contraceptive users.

Bernard C, Zhao Q, Peipert JF.

Eur J Contracept Reprod Health Care. 2018 Mar 27:1-8. doi: 10.1080/13625187.2018.1445850. [Epub ahead of print]

PMID:
29582687
2.

Long-acting reversible contraception use among residents in obstetrics/gynecology training programs.

Zigler RE, Peipert JF, Zhao Q, Maddipati R, McNicholas C.

Open Access J Contracept. 2017 Jan 10;8:1-7. doi: 10.2147/OAJC.S126771. eCollection 2017.

3.

Barriers and facilitators to implementing a patient-centered model of contraceptive provision in community health centers.

Politi MC, Estlund A, Milne A, Buckel CM, Peipert JF, Madden T.

Contracept Reprod Med. 2016 Nov 8;1:21. doi: 10.1186/s40834-016-0032-3. eCollection 2016.

4.

Anticipated pain as a predictor of discomfort with intrauterine device placement.

Dina B, Peipert LJ, Zhao Q, Peipert JF.

Am J Obstet Gynecol. 2018 Feb;218(2):236.e1-236.e9. doi: 10.1016/j.ajog.2017.10.017. Epub 2017 Nov 8.

PMID:
29079143
5.

Condom use and incident sexually transmitted infection after initiation of long-acting reversible contraception.

McNicholas CP, Klugman JB, Zhao Q, Peipert JF.

Am J Obstet Gynecol. 2017 Dec;217(6):672.e1-672.e6. doi: 10.1016/j.ajog.2017.09.009. Epub 2017 Sep 14.

PMID:
28919400
6.

Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.

Iseyemi A, Zhao Q, McNicholas C, Peipert JF.

Obstet Gynecol. 2017 Sep;130(3):609-615. doi: 10.1097/AOG.0000000000002189.

PMID:
28796678
7.

Relationship between nugent score and vaginal epithelial exfoliation.

Amegashie CP, Gilbert NM, Peipert JF, Allsworth JE, Lewis WG, Lewis AL.

PLoS One. 2017 May 31;12(5):e0177797. doi: 10.1371/journal.pone.0177797. eCollection 2017.

8.

Is It Time to Abandon the Routine Pelvic Examination in Asymptomatic Nonpregnant Women?

McNicholas C, Peipert JF.

JAMA. 2017 Mar 7;317(9):910-911. doi: 10.1001/jama.2017.0899. No abstract available.

PMID:
28267835
9.

Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.

McNicholas C, Swor E, Wan L, Peipert JF.

Am J Obstet Gynecol. 2017 Jun;216(6):586.e1-586.e6. doi: 10.1016/j.ajog.2017.01.036. Epub 2017 Jan 29.

PMID:
28147241
10.

Long-Acting Reversible Contraception.

Curtis KM, Peipert JF.

N Engl J Med. 2017 Feb 2;376(5):461-468. doi: 10.1056/NEJMcp1608736. Review. No abstract available.

PMID:
28146650
11.

Changes in body composition in women using long-acting reversible contraception.

Silva Dos Santos PN, Madden T, Omvig K, Peipert JF.

Contraception. 2017 Apr;95(4):382-389. doi: 10.1016/j.contraception.2016.12.006. Epub 2016 Dec 30.

12.

Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.

Diedrich JT, Klein DA, Peipert JF.

Am J Obstet Gynecol. 2017 Apr;216(4):364.e1-364.e12. doi: 10.1016/j.ajog.2016.12.024. Epub 2016 Dec 28. Review.

PMID:
28038902
13.

Reducing health disparities by removing cost, access, and knowledge barriers.

Goodman M, Onwumere O, Milam L, Peipert JF.

Am J Obstet Gynecol. 2017 Apr;216(4):382.e1-382.e5. doi: 10.1016/j.ajog.2016.12.015. Epub 2016 Dec 23.

PMID:
28024989
14.

Sexually transmitted diseases and infertility.

Tsevat DG, Wiesenfeld HC, Parks C, Peipert JF.

Am J Obstet Gynecol. 2017 Jan;216(1):1-9. doi: 10.1016/j.ajog.2016.08.008. Review.

15.

Validity of self-reported history of Chlamydia trachomatis infection.

Frisse AC, Marrazzo JM, Tutlam NT, Schreiber CA, Teal SB, Turok DK, Peipert JF.

Am J Obstet Gynecol. 2017 Apr;216(4):393.e1-393.e7. doi: 10.1016/j.ajog.2016.12.005. Epub 2016 Dec 14.

PMID:
27988270
16.

Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.

Mejia M, McNicholas C, Madden T, Peipert JF.

Contraception. 2016 Nov;94(5):556-560. doi: 10.1016/j.contraception.2016.06.013. Epub 2016 Jun 27.

17.

Reply.

Binder PS, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA.

Am J Obstet Gynecol. 2017 Feb;216(2):192-193. doi: 10.1016/j.ajog.2016.09.084. Epub 2016 Sep 15. No abstract available.

PMID:
27640937
18.

Surgical Management of Benign Adnexal Masses in the Pediatric/Adolescent Population: An 11-Year Review.

Bergeron LM, Bishop KC, Hoefgen HR, Abraham MS, Tutlam NT, Merritt DF, Peipert JF.

J Pediatr Adolesc Gynecol. 2017 Feb;30(1):123-127. doi: 10.1016/j.jpag.2016.09.002. Epub 2016 Sep 14.

PMID:
27639749
19.

Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.

Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK.

Am J Obstet Gynecol. 2016 Dec;215(6):766.e1-766.e9. doi: 10.1016/j.ajog.2016.07.035. Epub 2016 Jul 22.

20.

Sexual Behavior and Contraceptive Use at Brown University: 1975-2011.

Peipert BJ, Scott DM, Matteson KA, Clark MA, Zhao Q, Peipert JF.

J Reprod Med. 2016 Mar-Apr;61(3-4):101-8.

PMID:
27172631

Supplemental Content

Loading ...
Support Center